News Column

PACIRA PHARMACEUTICALS, INC. FILES (8-K) Disclosing Results of Operations and Financial Condition, Financial Statements and Exhibits

February 25, 2014



Item 2.02. Results of Operations and Financial Condition.

On February 25, 2014, we issued a press release announcing our results for the fourth quarter and full year ended December 31, 2013. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 2.02 of Form 8-K and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) The following exhibits are included in this report:

Exhibit No. Description 99.1 Earnings Press Release dated February 25, 2014 2



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools